Remimazolam
- Generic Name
- Remimazolam
- Brand Names
- Byfavo
- Drug Type
- Small Molecule
- Chemical Formula
- C21H19BrN4O2
- CAS Number
- 308242-62-8
- Unique Ingredient Identifier
- 7V4A8U16MB
- Background
Remimazolam is an ultra short-acting benzodiazepine used in the induction and maintenance of sedation during short (<30 minute) procedures. Recent trends in anesthesia-related drug development have touted the benefits of so-called "soft drugs" - these agents, such as remifentanil, are designed to be metabolically fragile and thus susceptible to rapid biotran...
- Indication
Remimazolam is indicated for the induction and maintenance of procedural sedation in adults undergoing procedures lasting 30 minutes or less.
- Associated Conditions
- Procedural Sedation
- Associated Therapies
- -
Effect of Remimazolam vs Sevoflurane Anesthesia on Incidence of Emergence Agitation and Complications in Children Undergoing Ophthalmic Surgery
- Conditions
- Interventions
- First Posted Date
- 2022-09-02
- Last Posted Date
- 2023-03-24
- Target Recruit Count
- 110
- Registration Number
- NCT05527314
- Locations
- 🇨🇳
the Second Affiliated Hospital of Nanchang University, Nanchang University, Nanchang, Jiangxi, China
Comparison of the Effect of Remimazolam With Sevoflurane on Postanesthetic Shivering
- First Posted Date
- 2022-08-31
- Last Posted Date
- 2022-08-31
- Lead Sponsor
- Wonkwang University Hospital
- Target Recruit Count
- 74
- Registration Number
- NCT05523037
- Locations
- 🇰🇷
Wonkwag UH, Iksan, Jeollabukdo, Korea, Republic of
Remimazolam and Scoliosis Orthopedics
- First Posted Date
- 2022-08-29
- Last Posted Date
- 2022-08-29
- Lead Sponsor
- Beijing Chao Yang Hospital
- Target Recruit Count
- 148
- Registration Number
- NCT05519371
Moderate Sedation Combined With Acupuncture Anesthesia in Gastroscopy and Colonoscopy on Screening Research
- Conditions
- Interventions
- First Posted Date
- 2022-08-03
- Last Posted Date
- 2022-11-04
- Lead Sponsor
- The Affiliated Hospital of Qingdao University
- Target Recruit Count
- 108
- Registration Number
- NCT05485064
- Locations
- 🇨🇳
Jixiangyu, Qingdao, Shandong, China
Clinical Application Value of Remazolam Combined With Sugammadex Sodium in Anesthesia for Endotracheal Surgery Under Bronchoscopy
- First Posted Date
- 2022-07-21
- Last Posted Date
- 2022-10-26
- Lead Sponsor
- Zhejiang Cancer Hospital
- Target Recruit Count
- 34
- Registration Number
- NCT05468671
- Locations
- 🇨🇳
Zhejiang Cancer Hospital, Hanzhou, China
Median Effective Dose of Remimazolam for Sedation in Elderly Patients
- First Posted Date
- 2022-07-21
- Last Posted Date
- 2023-04-21
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 60
- Registration Number
- NCT05468996
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
Comparison of Remimazolam and Dexmedetomidine for Intraoperative Sedation
- First Posted Date
- 2022-07-07
- Last Posted Date
- 2022-11-29
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 104
- Registration Number
- NCT05447507
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Jongno-gu, Korea, Republic of
Effect of Remimazolam on Postoperative Nausea and Vomiting
- Conditions
- Interventions
- First Posted Date
- 2022-06-30
- Last Posted Date
- 2023-07-28
- Lead Sponsor
- Inje University
- Target Recruit Count
- 108
- Registration Number
- NCT05439057
- Locations
- 🇰🇷
Sanggye Paik hospital, Seoul, Korea, Republic of
REmimazolam vs PrOpofol on Intraoperative hypotenSion in Major Noncardiac surgEry
- First Posted Date
- 2022-06-29
- Last Posted Date
- 2022-10-03
- Lead Sponsor
- Nanfang Hospital, Southern Medical University
- Target Recruit Count
- 340
- Registration Number
- NCT05436522
- Locations
- 🇨🇳
Nanfang Hospital, Southern Medical University, Guangzhou, China
The Effect of Remifentanil on ED95 of Remimazolam for Loss of Consciousness in Adult Patients
- First Posted Date
- 2022-06-28
- Last Posted Date
- 2022-06-28
- Lead Sponsor
- Ajou University School of Medicine
- Target Recruit Count
- 80
- Registration Number
- NCT05434494
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.